Jump Financial LLC bought a new stake in shares of Corteva, Inc. (NYSE:CTVA - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 14,415 shares of the company's stock, valued at approximately $821,000.
Other institutional investors also recently bought and sold shares of the company. Independent Franchise Partners LLP grew its holdings in shares of Corteva by 51.5% in the fourth quarter. Independent Franchise Partners LLP now owns 16,496,508 shares of the company's stock valued at $939,641,000 after purchasing an additional 5,604,838 shares in the last quarter. Norges Bank acquired a new position in shares of Corteva in the fourth quarter worth $251,892,000. Raymond James Financial Inc. purchased a new stake in shares of Corteva during the fourth quarter worth $161,052,000. Franklin Resources Inc. raised its stake in shares of Corteva by 9.2% in the fourth quarter. Franklin Resources Inc. now owns 16,143,025 shares of the company's stock valued at $919,507,000 after acquiring an additional 1,354,418 shares in the last quarter. Finally, B. Metzler seel. Sohn & Co. AG boosted its holdings in Corteva by 69.0% in the fourth quarter. B. Metzler seel. Sohn & Co. AG now owns 2,870,859 shares of the company's stock valued at $163,181,000 after purchasing an additional 1,172,110 shares during the period. 81.54% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
CTVA has been the topic of a number of analyst reports. Oppenheimer increased their price target on Corteva from $70.00 to $72.00 and gave the company an "outperform" rating in a research report on Friday, February 7th. KeyCorp boosted their price target on shares of Corteva from $70.00 to $71.00 and gave the stock an "overweight" rating in a report on Monday, April 14th. BNP Paribas upgraded shares of Corteva to a "hold" rating in a report on Monday, February 10th. UBS Group lowered their target price on shares of Corteva from $74.00 to $73.00 and set a "buy" rating for the company in a research note on Friday, January 10th. Finally, Wells Fargo & Company raised their price target on Corteva from $67.00 to $73.00 and gave the company an "overweight" rating in a research note on Tuesday, January 28th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $68.13.
View Our Latest Analysis on CTVA
Insiders Place Their Bets
In other Corteva news, insider Brian Titus sold 26,560 shares of the company's stock in a transaction on Thursday, February 20th. The stock was sold at an average price of $63.74, for a total value of $1,692,934.40. Following the sale, the insider now owns 11,347 shares of the company's stock, valued at approximately $723,257.78. This represents a 70.07 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.14% of the company's stock.
Corteva Stock Performance
Shares of Corteva stock traded down $0.21 during trading hours on Friday, hitting $61.50. 1,803,138 shares of the company were exchanged, compared to its average volume of 3,325,474. The stock has a market capitalization of $42.01 billion, a price-to-earnings ratio of 47.67, a P/E/G ratio of 1.68 and a beta of 0.73. The company has a current ratio of 1.45, a quick ratio of 0.93 and a debt-to-equity ratio of 0.08. Corteva, Inc. has a 1 year low of $50.01 and a 1 year high of $66.24. The business has a 50-day moving average of $60.71 and a 200-day moving average of $60.44.
Corteva (NYSE:CTVA - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. As a group, analysts expect that Corteva, Inc. will post 2.96 EPS for the current fiscal year.
Corteva Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Monday, March 3rd were issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 1.11%. The ex-dividend date was Monday, March 3rd. Corteva's dividend payout ratio (DPR) is currently 52.71%.
Corteva Profile
(
Free Report)
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
Further Reading
Before you consider Corteva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.
While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
